US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

36.95

-0.9597-2.53%

Post-market: 36.950.00000.00%16:10 EDT

Volume:799

Turnover:29.62K

Market Cap:2.77M

PE:- -

High:37.04

Open:37.04

Low:36.95

Close:37.91

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.71

T/O Rate:1.07%

Dividend:0.76

Dividend Rate:2.07%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ultragenyx confirms FDA approval of Fayuvi

FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A

Argenx Expands Kidney Pipeline With New IgA Nephropathy Trial

Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial

Argenx Se : Jefferies Raises Target Price to $1235 from $1215

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oscar Health (OSCR) and Argenx Se (ARGX)

Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/TBXU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":36.95,"timestamp":1790971200000,"preClose":37.9097,"halted":0,"volume":799,"hourTrading":{"tag":"盘后","latestPrice":36.95,"preClose":36.95,"latestTime":"16:10 EDT","volume":7,"amount":258.65,"timestamp":1790971805107,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.025315420591563585,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Market Closed","change":-0.9597,"latestTime":"10-02 16:00:00 EDT","open":37.04,"high":37.04,"low":36.95,"amount":29615,"amplitude":0.002374,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":37.9097,"sharesOutstanding":100001,"nav":36.998,"aum":2774874.6,"dividendRate":0.020691,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.28,"preClose":37.9097,"latestTime":"08:40 EDT","volume":3,"amount":117.84,"timestamp":1790944836091,"change":1.3703,"changeRate":0.036146,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.95,"preClose":36.95,"latestTime":"16:10 EDT","volume":7,"amount":258.65,"timestamp":1790971805107,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7050829571574564},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7050829571574564,"shares":75001,"dividePrice":0.76452,"high":37.04,"amplitude":0.002374,"preClose":37.9097,"low":36.95,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":36.95,"eps":0,"divideRate":0.020691,"volume":799,"delay":0,"ttmEps":0,"open":37.04,"prevYearClose":31.065,"prevWeekClose":40.5306,"prevMonthClose":39.9,"prevQuarterClose":39.9,"fiveDayClose":40.5306,"twentyDayClose":45.76,"sixtyDayClose":33.8804},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-09-22","symbol":"TBXU","amount":0.14204,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-22","defaultRemindTime":1790083800000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-22","currency":"USD","dateTimestamp":1790049600000,"payDate":"2026-09-29"},{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"},{"executeDate":"2026-09-22","recordDate":"2026-09-22","paymentDate":"2026-09-29","value":0.14204,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668994030","title":"Ultragenyx confirms FDA approval of Fayuvi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994030","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994030?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:55","pubTimestamp":1789674924,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) announced that the U.S. FDA granted standard full approval of Fayuvi, also known as UX111, for the treatment of pediatric patient...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","PINK","PSCH","BK4588","TBXU","TECB","LFSC","MRNX","LABU","BK4585","NVIB","BK4139","FRTY","IBB","RARE","BBP","IEIH","BMED","MRNY","XLVX","SYNB","RSPH","GDOC","IYH","GNMX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668991067","title":"FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A","url":"https://stock-news.laohu8.com/highlight/detail?id=2668991067","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668991067?lang=en_us&edition=fundamental","pubTime":"2026-09-18 02:35","pubTimestamp":1789670130,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration approved Fayuvi, which it calls “the first treatment for pediatric patients with mucopolysaccharidosis type I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","IBB","IBBQ","SYNB","FBT","BK4588","TBXU","CNCR","BK4585","GNOM","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668397999","title":"Argenx Expands Kidney Pipeline With New IgA Nephropathy Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668397999","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668397999?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662647,"startTime":"0","endTime":"0","summary":"Argenx ($ARGX) announced an update on their ongoing clinical study. Argenx (ARGX) is preparing a Phase 2 study called “A Phase 2, Multicenter, Rand...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenx-expands-kidney-pipeline-with-new-iga-nephropathy-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenx-expands-kidney-pipeline-with-new-iga-nephropathy-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","IE0034235188.USD","TBXU","LU0320765992.SGD","LU0390134368.USD","ARGX","BK4505","IE00B2B36J28.USD","LU1983260115.SGD","IE00BJJMRZ35.SGD","LU0823416689.USD","IE0002141913.USD","FMED","BK4139","BK4585","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IBB","IE00BJT1NW94.SGD","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993629","title":"Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993629","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993629?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662630,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running a Phase 3 study testing romiplostim plus predni...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","ITP","PJP","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4581","IBBQ","BK4534","IE0002141913.USD","PBE","LU0109394709.USD","BK4199","BIB","BBH","LU2089984988.USD","IBB","LU1061106388.HKD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4588","LU0320765992.SGD","LU1571399168.USD","LU2468319806.SGD","IE0009355771.USD","SG9999001440.SGD","LU2242646821.SGD","BK4599","LU0122379950.USD","LU0868494617.USD","LU0289739699.SGD","LU1057294990.SGD","IE00B4R5TH58.HKD","BK4533","BK4585","LU2112291526.USD","LU2242652126.USD","LU1983299246.USD","AMGN","LU1023059063.AUD","TBXU","LU0889565916.HKD","BK4139","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668998797","title":"Argenx Se : Jefferies Raises Target Price to $1235 from $1215","url":"https://stock-news.laohu8.com/highlight/detail?id=2668998797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668998797?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:13","pubTimestamp":1789654381,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IE00BFTCPJ56.SGD","BK4585","FMED","IE00BJJMRZ35.SGD","LU0390134368.USD","LU1983260115.SGD","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4588","IE0002141913.USD","LU0320765992.SGD","IBB","LU0823416689.USD","LU2324357040.USD","IE0034235188.USD","LU0109394709.USD","ARGX","IE00B2B36J28.USD","TBXU","BK4505","IE00BJT1NW94.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962770","title":"Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962770?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:40","pubTimestamp":1789648810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and Amgen (AMGN) with bulli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU2089984988.USD","LU2242646821.SGD","LU0128526141.USD","IE00B2B36J28.USD","LU0029874061.USD","BK4139","LU0122379950.USD","LU0757428866.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","HCSG","BIB","IE00BFMHRM44.USD","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","LU0289739699.SGD","LU0390134368.USD","LU1061106388.HKD","BK4566","LU1057294990.SGD","XLV","BBH","PJP","IE00BJJMRZ35.SGD","BK4581","LU2112291526.USD","IE0009355771.USD","BK4585","AMGN","BK4530","LU0889565916.HKD","BK4533","TBXU","BK4599","SG9999001440.SGD","LU1983299246.USD","BK4137","CRL","IBBQ","LABU","LU0868494617.USD","BK4121","IE00BJT1NW94.SGD","LU1815336091.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996120","title":"Nuvation Bio announces FDA approval of sNDA for Ibtrozi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996120","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996120?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:35","pubTimestamp":1789644932,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced that the U.S. FDA has approved a supplemental New Drug Application for Ibtrozi, a ROS1 inhibitor approved for the tre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","RSPH","GNMX","LFSC","XLVX","PINK","NVIB","SYNB","MRNY","IBB","IYH","PSCH","BK4588","MEDI","GDOC","BK4007","TECB","IEIH","NUVB","FRTY","BMED","BK4585","TBXU","BBP","LABU","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961345","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961345?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:10","pubTimestamp":1789643407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Atricure (ATRC) and Stryker (SYK) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU2468319806.SGD","LU0029874061.USD","XLV","LU1571399168.USD","BK4585","LU2404859667.USD","LU2506951875.HKD","XBI","SYK","IHI","LU0128526141.USD","BK4534","IBB","LU0690374961.EUR","LU2506952097.USD","GB00B4LPDJ14.GBP","BIB","IBBQ","LU2242652126.USD","LU0528227936.USD","AMGN","BBH","IE0002141913.USD","BK4599","GB00B4QBRK32.GBP","BK4581","LABU","LU0868494617.USD","LU2324357040.USD","TBXU","LU0058720904.USD","LU2404859741.USD","LU2089984988.USD","LU0882574055.USD","HCSG","LU2362541513.USD","LU0109394709.USD","LU2362540622.SGD","LU2362541273.HKD","IE00BJT1NW94.SGD","LU1061106388.HKD","BK4588","LU0690374615.EUR","PJP","PBE","LU0823417653.USD","ATRC","BK4082","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963550","title":"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963550?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637460,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Malaysian copper-composite manufacturer Vertex Material plans to go public in the U.S. next year after achieving a reported valuation of about $7 billion.The advanced-materials","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPXR","IDNA","VRTX","ICOP","IE00B2B36J28.USD","IE0002270589.USD","LU1430594728.SGD","BK4023","LU2237438978.USD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","LU0256863811.USD","VERX","IE00B19Z9Z06.USD","BK4139","IE00B19Z9P08.USD","COPP","IE0009355771.USD","LU2468319806.SGD","LU0823416689.USD","LU2324357040.USD","LU2462157665.USD","GNMX","BBH","IBBQ","XME","LU0320765992.SGD","LU0566484027.USD","COPJ","LU1035775433.USD","QCmain","LU2362541513.USD","LU2236285917.USD","BIB","LU1093756325.SGD","LU2417539215.USD","LU0889565916.HKD","UYM","CPER","BK4532","LU2089984988.USD","IBB","LU1778281490.HKD","MHGmain","TBXU","SG9999013999.USD","LU1069344957.HKD","LU0432979614.USD","PBE","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963474","title":"Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963474?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637420,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that theFDA approved Kerendia to reduce urinary albumin-to-creatinine ratio, which is expected to reduce the risk of sustai...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVIB","GNMX","MRNX","MEDI","IDNA","PINK","BK4588","SYNB","GDOC","BBP","LABU","PSCH","BMED","FRTY","TBXU","TECB","MRNY","IYH","XLVX","BAYRY","LFSC","IEIH","IBB","RSPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668405963","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oscar Health (OSCR) and Argenx Se (ARGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668405963","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668405963?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637410,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Oscar Health (OSCR) and Argenx Se (ARGX). Oscar He...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-oscar-health-oscr-and-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-oscar-health-oscr-and-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","ARGX","HEAL","IE00B2B36J28.USD","BK4139","IE00BJJMRZ35.SGD","OSCX","IBB","BK4588","TBXU","IE0002141913.USD","IE0034235188.USD","LU0320765992.SGD","BK4585","LU0889565916.HKD","BK4505","BK4551","IE0009355771.USD","LU0823416689.USD","FMED","OSCG","LU0390134368.USD","BK4162","LU1983260115.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU2324357040.USD","OSCR","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668936994","title":"Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668936994","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668936994?lang=en_us&edition=fundamental","pubTime":"2026-09-17 05:35","pubTimestamp":1789594520,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced topline results from ELPIS II, its Phase 2b clinical trial evaluating its investigational stem cell therapy laromestroc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","BK4585","TBXU","BK4139","GNOM","IBB","BK4588","HYLG","LGVN","FBT","MEDX","CNCR","SYNB","GDOC","LFSC","IBBQ","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668593306","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593306","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593306?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:28","pubTimestamp":1789590524,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier sells USD 431,819 of common stockGilead: Chief Comm & Corp Aff Officer Johanna Mercier sold 3,000 common shares on Sep. 15, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6sfPNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU2087621335.USD","LU0289739699.SGD","LU1585245621.USD","MEDI","LU0109394709.USD","BBH","LU0122379950.USD","BK4550","LU0859254822.USD","IE0002270589.USD","IBBQ","BK4568","LU1674673428.USD","LU2089984988.USD","GILD","LU1674673691.USD","BK4566","BMED","LU0114720955.EUR","LU2357627491.SGD","BIB","IE00BSNM7G36.USD","LU1066053197.SGD","BK4588","IE00B19Z3B42.SGD","LU0965509283.SGD","BK4532","LU0882574055.USD","IE00B19Z3581.USD","TBXU","LU0965509101.SGD","LU0320765992.SGD","TMED","LU1023059063.AUD","IBB","LU1778281490.HKD","LU0234570918.USD","BK4578","SG9999015945.SGD","LU1430594728.SGD","BK4585","IE00BKVL7J92.USD","SG9999015986.USD","IE00B3T34201.USD","LU1066051498.USD","SG9999015952.SGD","LU0823416689.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983112","title":"Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983112?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:30","pubTimestamp":1789561801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA4XXCG2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU0114720955.EUR","LU1571399168.USD","LU0234570918.USD","GILD","IE00BKVL7J92.USD","LU1023059063.AUD","LU1585245621.USD","SG9999015945.SGD","SG9999015952.SGD","IBB","LU1057294990.SGD","IE00B19Z3581.USD","MEDI","LU0965509283.SGD","BIB","SG9999015978.USD","IBBQ","BK4550","LU1839511570.USD","LU2112291526.USD","LU1037948897.HKD","BBH","BK4568","LU0965509101.SGD","LU1934455863.HKD","IE00B7SZLL34.SGD","LU0122379950.USD","LU2324357040.USD","TBXU","TMED","LU0058720904.USD","LU1037948541.HKD","LU2089984988.USD","LU0859254822.USD","LU2357627491.SGD","BMED","LU0109394709.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU1934455277.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU1061106388.HKD","LU1430594728.SGD","LU2087621335.USD","LU0823416689.USD","LU0882574055.USD","IE00B3T34201.USD","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667979600","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667979600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667979600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU1069344957.HKD","IE00BJJMRZ35.SGD","IDNA","VRTX","BIB","LABU","IE00B894F039.SGD","GNMX","CRL","LU0390134368.USD","IE00BZ9MQY76.HKD","LU2362541273.HKD","XLV","BBH","LU2362540622.SGD","LU0109394709.USD","LU1585245621.USD","LU0289739699.SGD","MEDI","XBI","SGXZ57979304.SGD","LU2324357040.USD","IE0009355771.USD","IBBQ","LU0029874061.USD","LU1430594728.SGD","LU1093756168.USD","LU2237438978.USD","VERX","LU0061475181.USD","BK4585","LU1093756325.SGD","LU1559883803.SGD","LU2462157665.USD","BK4023","LU2236285917.USD","IBB","BK4533","LU0889565916.HKD","TBXU","LU2417539215.USD","BK4588","BK4581","HCSG","LU0757428866.USD","LU1035775433.USD","LU1778281490.HKD","ASND","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600950","title":"The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600950?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557600,"startTime":"0","endTime":"0","summary":"T. Rowe Price manager looks for trouble to find his global value betsT.Rowe Price manager Sebastien Mallet is betting on more than technology for his five-star fund.One secret to global value manager Sebastien Mallet's success?","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000304797.USD","LU0496365809.HKD","BK4605","SKHL","LU0211326839.USD","LU2106854487.HKD","LU0208291251.USD","LU2177674079.SGD","BMED","LU0211331839.USD","BK4007","LU0889566641.SGD","LU0006306889.USD","LU0882574139.USD","SG9999004303.SGD","INYY","LU0823421416.USD","LU0082616367.USD","IE00BYXW3230.USD","LU2461242641.AUD","SKHZ","BKNG","LU0133085943.USD","LU0889565916.HKD","LU0820561818.USD","LU0234570918.USD","LU0323591593.USD","SG9999015978.USD","IE000SO60NU8.SGD","SIL","SKHX","SLVR","LU2168564222.USD","LU1366333091.USD","LU0823413660.USD","LU2236285917.USD","LU0266013472.USD","LU0432979614.USD","AMDG","LU0316494557.USD","LU0683600562.USD","LU0965509283.SGD","LU2357627491.SGD","LU0256863811.USD","LU0345770308.USD","SGXZ23171101.USD","SG9999002224.SGD","WISE","LU0390134368.USD","BK4614","LU0029864427.USD","SINTCmain","LU0154236417.USD","LU0345769631.USD","LU0251142724.SGD","BK4535","LU0823434583.USD","SKHY","LU0157215616.USD","AMYY","LU1956131251.USD","IE00BQXX3C00.GBP","IE00BDCRKT87.USD","LU0106261372.USD","LU2250418816.HKD","LU0127658192.USD","BK4612","LU2552382058.USD","WPM","SAMD0main","LU0256863902.USD","JPMO","IE00B5TLWC47.USD","LU0310800379.SGD","LU1496350171.SGD","INTW","LU1116320901.HKD","LU1066053197.SGD","LU0417517546.SGD","LU1242518931.SGD","LU1244550494.USD","SMHX","LU0820561909.HKD","AIS","LU0114720955.EUR","LU2148611432.USD","IE00B1BXHZ80.USD","LU2211815571.USD","JBHT","IE00BLSP4452.SGD","LU1720051017.SGD","LU1917777945.USD","SKHQ","BK4534","LU1861215975.USD","LU2054465674.USD","LU0203345920.USD","LU2931357623.SGD","LU2237443465.HKD","LU2355687059.USD","LU0823413587.USD","BK4232","IE0034235303.USD","LU0081259029.USD","LU2290526834.HKD","IE00BJTD4N35.SGD","LU2108987350.USD","LU0345774391.USD","SKUU","BK4554","LU0321505439.SGD","LU1988902786.USD","AMDY","WNDR","LU0868494617.USD","04335","BK4533","IXG","LU0868494708.USD","AMDU","LU0719512351.SGD","LU0882574055.USD","LU2746668974.SGD","LU0823416689.USD","LU0128525929.USD","BK4578","LU1670627923.USD","INT","BK4561","IE00BJTD4V19.USD","LU0077335932.USD","BK4022","HK0000304805.HKD","BKNU","LU2756315318.SGD","LU0353189763.USD","LU0654597011.USD","LU0792757196.USD","IE00BZ1G4Q59.USD","07709","LU1974910355.USD","LU2592432038.USD","LU0320765992.SGD","LU1852331112.SGD","LU1914381329.SGD","LU1496350502.SGD","FMTL","LU1121112475.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","QQQA","SG9999002232.USD","SOXY","LU2505996509.AUD","LU0612318971.USD","LU1551013342.USD","LU1861558580.USD","LU1934455277.USD","IE00B775SV38.USD","DAMD","LU2471134952.CNY","LU0187121727.USD","LU2896262040.SGD","LU1119994496.HKD","LU1674673428.USD","PSI","LU1551013425.SGD","ARTY","LU1023059063.AUD","IE000BZT7R73.USD","LU0210536198.USD","LU2750360997.AUD","LU1037948897.HKD","BK4581","KBWB","LU1674673691.USD","IE00BDRTCR15.USD","LU0965508806.USD","LU2471134796.USD","IE0002270589.USD","BK4585","LU1150488135.SGD","IE00B7SZLL34.SGD","LU0786609619.USD","AMUU","WUGI","IE00BK4W5M84.HKD","LU1232071149.USD","LU1244550577.SGD","GAMR","LU1064131342.USD","LU2764263203.CNY","BK4588","LU1145028129.USD","BK4548","SG9999001440.SGD","LU0109394709.USD","SG9999015986.USD","LU2750360641.GBP","LINT","BK4568","SKDD","IE0034235295.USD","LU1670628061.USD","SGXZ81514606.USD","LU1267930573.SGD","LU1829250122.USD","IYF","LU0787776722.HKD","LU1084165304.USD","LU0106831901.USD","BAI","HYNX","LU0964807845.USD","BK4515","SILJ","AMDS","LU1043141396.HKD","LU2720916845.USD","IE00BMPRXR70.SGD","LU1880398471.USD","LU2468319806.SGD","GILD","LU2357305700.SGD","LU1057294990.SGD","LU2089984988.USD","LU0048584097.USD","LU2430703251.USD","IE00BSNM7G36.USD","DRIV","LU1043141123.HKD","LU2237957811.SGD","LU0238689110.USD","LU0689472784.USD","BK4579","LU0943347566.SGD","LU1236620834.HKD","LU2112291526.USD","LU0122379950.USD","LU2860962120.EUR","LU2552382215.SGD","LU1699723380.USD","LU1280957306.USD","LU1066051498.USD","LU2324357040.USD","LU2168564149.EUR","IE00BKVL7J92.USD","LU2764262908.HKD","LU0823411888.USD","TBXU","LU1548497426.USD","LU0965509010.AUD","IE0009356076.USD","TFNS","BK4207","ILDR","XLF","LU0225283273.USD","FNCL","LU1236620750.USD","FNV","LU0149725797.USD","LU1629891620.HKD","IE00BKDWB100.SGD","LU0345769128.USD","LU0215105999.USD","LU0265550359.USD","LU0251132253.USD","AMDW","LU0321505868.SGD","LU2430703095.HKD","LU0861579265.USD","LU0211328371.USD","IE00B3T34201.USD","IE000F7OJYX1.SGD","LU2361045086.USD","TEK","LU2237443895.HKD","LU1267930490.SGD","LU0353189680.USD","FTXL","LU1861559042.SGD","LU2087621335.USD","LU1803068979.SGD","LU1242518857.USD","LU2237957902.USD","IE0034235188.USD","SG9999001424.SGD","IE00BMPRXQ63.HKD","LU0994945656.USD","IE00BN8TJ469.HKD","LU1162221912.USD","LU0859254822.USD","LU2264538146.SGD","BK4512","LU0612318385.USD","LU1894683348.USD","LU0823421333.USD","LU0070302665.USD","BK4504","LU2242649171.HKD","LU0426417589.USD","AZN","LU1804176565.USD","LU1037948541.HKD","LU0274383776.USD","LU0823434740.USD","IE000M9KFDE8.USD","LU2168563687.JPY","LU1116320737.USD","BK4543","LU1261432733.SGD","BK4550","BK4583","VFH","LU0320765489.SGD","IE00BQXX3D17.EUR","LU1989764748.USD","LU2505996681.GBP","LU0742534661.SGD","IE00BQXX3F31.USD","BK4573","LU2237443382.USD","GDX","LU0097036916.USD","IE00B5949003.HKD","CHAT","BK4532","LU1894683264.USD","LU2168564065.EUR","SKHA","IYG","IETC","LU1923623000.USD","CHPS","AMDD","LU2023250843.SGD","LU0267386448.USD","MEDI","BBH","BK4566","AIQ","LU2361044949.HKD","LU0965509101.SGD","LU1303367103.USD","SG9999015945.SGD","LU0203347892.USD","LU2023250504.SGD","SKHN","BK4520","LU2265009873.SGD","SG9999015952.SGD","LU1363072403.SGD","LU0048573561.USD","BK4567","LU2462157665.USD","LU1934455194.USD","BIB","AMDC","LU0211326755.USD","IE00B3S45H60.SGD","LU0640476718.USD","LU2360107168.USD","SK","GLDN","LU2381873111.SGD","TTEQ","LU2247934214.USD","IE00BHPRN162.USD","LU2552382132.HKD","BK4529","IE0001KFT4U8.USD","BK4142","LU0198837287.USD","TRFK","XNTK","IE00BJLML261.HKD","LU2458330169.SGD","LU2213496289.HKD","LU0823397285.USD","SKHYV","LU2097829019.USD","LU2244417387.USD","LU2756315664.SGD","IBBQ","LU0642271901.SGD","LU0979878070.USD","LU1934455863.HKD","LU0823397103.USD","LU0889565833.HKD","LU0251131958.USD","LU0345770993.USD","LU1989764664.SGD","LU2087625088.SGD","IE00BFXG1179.USD","LU2456880835.USD","LU1267930813.SGD","LU2168564495.EUR","LU1861220033.SGD","LU1244550221.USD","FAI","LU0708994859.HKD","LU2462591350.SGD","AWAY","BK4516","LU0310799852.SGD","BK4135","IE0004445239.USD","LU1880398554.USD","IE0000B7K699.USD","LU1720051108.HKD","AUAU","LU0942090050.USD","LU1585245621.USD","LU2237443549.SGD","LU2098885051.SGD","LU0320765646.SGD","LU2458330243.SGD","LU2764263039.SGD","LU0557290698.USD","IE00BMPRXN33.USD","TMED","LU0056508442.USD","LU0976567544.SGD","LU1032466523.USD","LU1951198990.SGD","AMDL","SMH","BK4139","IE00B1XK9C88.USD","IE000WAW04H5.SGD","IE00BK4W5L77.USD","LU1989772840.SGD","LU0289739699.SGD","CNAV","BK4527","FTXO","LU0211327993.USD","JPM","LU0174119429.USD","LU0170899867.USD","IE000MB6IJN5.SGD","LU0820562030.AUD","LU1316542783.SGD","LU1839511570.USD","LU2237443978.SGD","LU2360106780.USD","BK4602","INTC","GOAU","LU0234572021.USD","LU2471134879.HKD","LU1430594728.SGD","LU1951200564.SGD","LU1571399168.USD","LU0109392836.USD","LU1668664300.SGD","LU2008162690.USD","LU2543165471.USD","TROW","BK4141","IE00BWXC8680.SGD","LU1778281490.HKD","LEGR","LU1150488218.USD","LU0345774631.USD","LU0265550946.USD","AZNH","AMD","LU2089985449.USD","SGXZ51526630.SGD","UYG","LU1989772923.USD","SOXX","LU1061106388.HKD","LU2417539215.USD","SKHU","LU0426412945.USD","LU2237443622.USD","LU2023250330.USD","LU2361044865.SGD","USXF","JPO","LU0971096721.USD","LU1366192091.USD","BK4017","IE00BLSP4239.USD","TRUF","BK4575","LU2430703178.SGD","IBB","LU1430597077.USD","LU2471134523.USD","LU0058720904.USD","LU2746668461.USD","SGXZ99366536.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607925","title":"Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607925?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":"Sling Therapeutics raises $123 million to advance thyroid eye disease drugSept 16 (Reuters)-Drug developer Sling Therapeutics said on Wednesday ithad raised $123 million to advance a late-stage trial ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N457178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU1983299246.USD","LU2468319806.SGD","VRDN","BK4585","BK4599","IBB","BIB","PBE","LU2112291526.USD","AMGN","BK4566","PJP","LU0320765992.SGD","BK4581","IE00B4R5TH58.HKD","LU1061106388.HKD","LU0889565916.HKD","LU2089984988.USD","IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0058720904.USD","BK4534","BK4588","LU0868494617.USD","LU1023059063.AUD","LU0122379950.USD","TBXU","BBH","LU0109394709.USD","LU0289739699.SGD","BK4533","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU1571399168.USD","LU1057294990.SGD","BK4139","LU2242652126.USD","IE00BFTCPJ56.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832674","title":"Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832674?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530442,"startTime":"0","endTime":"0","summary":"Rohto starts Phase II trial of RE-01 cell therapy for refractory ischemic leg ulcersRohto began CDMO manufacturing for RE-01 cell therapy used in a Phase II investigator-led trial for refractory ische","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLJMrSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","IBB","IE00BZ1G4Q59.USD","LU1674673691.USD","BK4578","LU0122379950.USD","LU2112291526.USD","BMED","LU0234570918.USD","LU1037948541.HKD","LU0823416689.USD","LU0289739699.SGD","LU0114720955.EUR","LU1585245621.USD","LU1066051498.USD","LU1839511570.USD","TMED","LU1066053197.SGD","SG9999015978.USD","LU2468319806.SGD","IE00BKVL7J92.USD","BK4532","LU2089984988.USD","LU2357627491.SGD","LU1778281490.HKD","BK4583","MEDI","LU1057294990.SGD","LU0965509283.SGD","LU1061106388.HKD","LU1037948897.HKD","LU0320765992.SGD","LU1934455194.USD","GILD","LU0058720904.USD","LU0889565916.HKD","IE00B7SZLL34.SGD","BIB","LU0861579265.USD","BBH","LU1430594728.SGD","BK4568","BK4550","LU1934455863.HKD","SG9999015986.USD","SG9999015945.SGD","LU0965509010.AUD","TBXU","IBBQ","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624218","title":"Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624218","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624218?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:25","pubTimestamp":1789503924,"startTime":"0","endTime":"0","summary":"UPDATE 1-Bristol Myers sues Amgen over proposed Opdivo biosimilarSept 15 (Reuters)-Bristol Myers SquibbBMY.Nand Ono Pharmaceutical4528.Thave sued AmgenAMGN.Oin Delaware federal court, seeking to block","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N457192:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1571399168.USD","LU1061106388.HKD","TBXU","LU0225284248.USD","IBBQ","LU0868494617.USD","LU0237698245.USD","LU1585245621.USD","LU1883839398.USD","LU0061475181.USD","BMY","LU2596442595.SGD","LU0306806265.USD","BIB","LU1868836757.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU2112291526.USD","LU1868837136.USD","LU1236620834.HKD","FTXH","LU2468319806.SGD","IBB","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU2242646821.SGD","BK4532","LU0321505439.SGD","LU1670711040.USD","LU1718418525.SGD","LU1670710588.SGD","PBE","LU2242652126.USD","LU1093756168.USD","LU0267386448.USD","LU0432979614.USD","LU0058720904.USD","BK4533","IE00BFXG1179.USD","LU1670711123.USD","LU1323610961.USD","BK4588","LU1291159041.SGD","LU2125154778.USD","LU0109394709.USD","LU1868837300.USD","LU1430594728.SGD","BK4599","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU1032466523.USD","AMGN","LU1074936037.SGD","BK4559","IE00B2B36J28.USD","LU0096364046.USD","PJP","LU0289739699.SGD","LU1670710661.SGD","SG9999001440.SGD","BK4534","04332","BK4139","LU0456855351.SGD","IE0009355771.USD","LU1236620750.USD","BK4566","BK4007","LU1261432733.SGD","LU0225771236.USD","LU1868836591.USD","LU0882574055.USD","IHE","LU2125154935.USD","LU0306807586.USD","LU0889565916.HKD","LU0320765992.SGD","LU0321505868.SGD","LU2089984988.USD","BK4585","LU1023059063.AUD","BBH","LU1057294990.SGD","LU0985481810.HKD","LU1983299246.USD","LU2360032135.SGD","LU2133065610.SGD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["RSPH","MEDI","BBP","SYNB","TBXU","IYH","BMED","XBIX","IDNA","GNMX","GDOC","FRTY","MRNY","PSCH","LABU","TECB","XLVX","BK4585","NVIB","MRNX","IBB","LFSC","BK4588","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}